Fundz

Lexogen Receives FFG Funding to Develop a Novel SARS-CoV-2 Test for Mass Screening

PRIVATEApr 29, 2020

Round Type

Funding Round

AustriaBiotechnologyHealth Care

Description

Lexogen GmbH, a Vienna based Next-Generation Sequencing (NGS) and transcriptomics company, receives funding from the Austria Research Promotion Agency (FFG) for the development of a novel SARS-CoV-2 test method for mass screening.

Quick answer

Lexogen raised an undisclosed amount in a Funding Round round, dated April 29, 2020. Lexogen is based in Austria.

How much did Lexogen raise?
Lexogen raised an undisclosed amount in a Funding Round round on April 29, 2020.
What does Lexogen do?
Lexogen is a biotechnology company based in Vienna, specializing in RNA transcriptomics technologies and services.
Where is Lexogen based and how big is it?
Lexogen is based in Austria.
Who are the decision-makers at Lexogen?
Fundz holds 4 contacts at Lexogen, including the Quality Control. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Lexogen that raised within 45 days of this round, from Fundz verified event records.

  • Life Biosciences raised $18M on June 12, 2020.
  • Mereo Biopharma Group plc raised $70M on June 12, 2020.
  • LeonaBio, Inc. raised $89M on June 12, 2020.
  • BioLineRx Ltd raised $9M on June 10, 2020.
  • Canopy raised $2M (Seed) on June 10, 2020.
  • MedinCell raised $5.4M (Debt Financing) on June 10, 2020.

Who to call at Lexogen, and when

A new round usually means Lexogen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lexogen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lexogen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lexogen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lexogen

Location

Austria

About

Lexogen is a biotechnology company based in Vienna, specializing in RNA transcriptomics technologies and services. They provide high-quality RNA sequencing data from various samples using proprietary technologies to support researchers and companies in developing therapies and diagnostic tools. Lexogen NGS Services operates in compliance with stringent standards and is dedicated to delivering reliable and precise data to accelerate innovation in the life sciences.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lexogen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsAlexander S., Quality Control hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Lexogen's next move

See what Strategic adds

Lexogen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.